See also this year's filing and all EDGAR filings for this company.
PDF Report 0001623526_2022_Stoke_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001623526')"} |
Graph
Absolute values for 0001623526, Stoke Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 229,218,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,139,000 |
| 3 | remainder_Assets | 5,508,000 |
| 4 | LiabilitiesCurrent | 17,139,000 |
| 5 | LiabilitiesNoncurrent | 3,949,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,897,000 |
| 9 | ResearchAndDevelopmentExpense | 54,168,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 260,000 |
| 13 | remainder_ComprehensiveNetIncome | -168,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 238,865,000 |
| 1 | Liabilities | 21,088,000 |
| 2 | Expenses | 86,065,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 217,777,000 |
| 5 | NetIncome | -85,805,000 |
| 6 | ComprehensiveNetIncome | -85,889,000 |
| 7 | BaseVar | 173,223,000 |
| 8 | EconomicCapitalRatio | 2.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
